Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 11.61
+0.18 (1.57%)
Sep 30, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 12.65 billion as of October 2, 2026. Its market cap has increased by 20.41% in one year.
Market Cap
12.65B
Enterprise Value
11.20B
Revenue
1.53B
Ranking
n/a
PE Ratio
91.19
Stock Price
11.61
ChartMarket Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 12.65B, an increase of 1,194.41%. That is a compound annual growth rate of 9.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 12.65B | -23.16% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 14.35B |
| Shanghai Medicilon | 14.16B |
| Nanjing Vazyme Biotech | 14.08B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |
| Hualan Biological Vaccine | 11.97B |
| Mabwell (Shanghai) Bioscience | 11.61B |
| Shanghai OPM Biosciences | 11.32B |